Skip to content

The difference in fractional cholesterol absorption between subjects with high versus low plasma campesterol levels

The difference in fractional cholesterol absorption between subjects with high versus low plasma campesterol levels - DAHLIA-2

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32507
Enrollment
13
Registered
2009-01-14
Start date
2008-12-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mild hypercholesterolaemia slightly elevated cholesterol

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy male and female subjects, aged 18-65 years old, with an LDL-cholesterol concentration between 3.0 and 5.0 mmol/l, who participated in the Dahlia-1 study and belong to the 6 subjects with the highest or to the 6 subjects with the lowest plasma campesterol levels respectively. One subject with the subsequently highest campesterol levels will be asked to undergo a cholesterolabsorption measurement as well, in order for us to test the quantification of cholesterol isotopes by our laboratory.

Exclusion criteria

Exclusion criteria: Excluded are persons with a genetic hyperlipoproteinemia like familial hypercholesterolemia, LPL-deficiency, familial dysbeta lipoproteinemia and familial hypertriglyceridemia. Also people with diabetes mellitus, severe hypertriglyceridemia, uncontrolled hypertension or history of arterial disease including unstable angina, myocardial infarction, recent transient ischaemic attacks or a cerebro-vascular accident, will be excluded.

Design outcomes

Primary

MeasureTime frame
The difference in fractional cholesterol absorption, as measured by means of the dual isotope method, between subjects with high and low plasma campesterol levels respectively.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)